ALPHA LIPOIC ACID (GRANULAR) (ALA)

WHAT IS ALPHA LIPOIC ACID (GRANULAR) (ALA)?

Alpha Lipoic Acid (Granular) (ALA), also known as granular thioctic acid and granular lipoic acid, is alpha lipoic acid presented as granules rather than an unspecified fine powder. The granules can consist of crystalline material or another declared physical preparation. The supplier's composition and manufacturing description establish what the granular product actually contains.

The common name thioctic acid refers to the same core chemical identity. Lipoic acid and alpha-lipoic acid are also widely used names in technical literature. The alpha designation is normally retained when a precise product description is needed.

The acid contains eight carbon atoms and two sulfur atoms. Its ring includes a sulfur–sulfur bond, while the side chain terminates in a carboxylic acid group. These structural features explain why both redox behavior and pH dependent formulation behavior are relevant.

A conventional racemic product contains both mirror image forms. The R and S molecules have the same formula but different spatial arrangement around the chiral center. A routine total assay does not necessarily determine their relative proportions. Granulation is a physical form distinction. It can influence exposed surface area, flow, segregation, and the speed of dissolution. It does not create a new molecular species or guarantee improved biological performance.

A coated product is a further distinction. A coating or carrier can change active content, wetting, release, and compatibility. The term granular should not be interpreted as a declaration that a coating is present or absent. A finished tablet or capsule is different from the bulk ingredient. Excipients, processing, packaging, and the finished product specification contribute to its performance. The raw material certificate cannot establish every property of the eventual dosage form.

The abbreviation ALA should be defined in technical records. It can identify other compounds in different contexts, including alpha-linolenic acid. The full name and CAS number prevent confusion in ordering, laboratory work, and formulation transfer.

Common Product and Chemical Names

- Exact requested product name: ALPHA LIPOIC ACID (GRANULAR) (ALA)
- Common chemical name: Alpha lipoic acid
- Hyphenated spelling: Alpha-lipoic acid
- Symbol based spelling: α-Lipoic acid
- Established common synonym: Thioctic acid
- General abbreviated name: Lipoic acid
- Conventional racemic name: DL-alpha-lipoic acid
- Symbol based racemic name: DL-α-lipoic acid
- Alternative racemic wording: DL-thioctic acid
- Alternative racemic designation: (±)-alpha-lipoic acid
- Symbol based designation: (±)-α-lipoic acid
- Stereochemical designation: (RS)-alpha-lipoic acid
- Alternative stereochemical designation: (RS)-thioctic acid
- Structural name: 5-(1,2-dithiolan-3-yl)pentanoic acid
- Alternative structural wording: 1,2-Dithiolane-3-pentanoic acid
- Alternative chain name: 1,2-Dithiolane-3-valeric acid
- Racemic structural wording: (±)-1,2-Dithiolane-3-pentanoic acid
- Racemic alternative wording: (±)-1,2-Dithiolane-3-valeric acid
- Established descriptive name: 6,8-Dithiooctanoic acid
- Alternative historical wording: DL-6,8-thioctic acid
- Form specific description: Granular alpha lipoic acid
- Form specific synonym: Thioctic acid granules
- Defined abbreviation: ALA
- Alternative defined abbreviation: α-LA
- Short abbreviation requiring context: LA

For Alpha Lipoic Acid (Granular) (ALA), thioctic acid and lipoic acid are the most useful alternatives to the longer product name in ordinary technical prose. DL-thioctic acid, DL-alpha-lipoic acid, and (RS)-thioctic acid emphasize the conventional racemic identity. Their relevance should be confirmed for the offered grade rather than inferred from granule size.

The expressions (±)-alpha-lipoic acid and (±)-α-lipoic acid likewise describe a racemate. DL-α-lipoic acid and (RS)-alpha-lipoic acid are equivalent naming conventions when the material is appropriately specified. A pure R form should not be relabeled as a racemic synonym.

The name 5-(1,2-dithiolan-3-yl)pentanoic acid makes the ring and acid side chain explicit. The alternative expressions 1,2-dithiolane-3-pentanoic acid and 1,2-dithiolane-3-valeric acid describe the same structural framework. The corresponding racemic names, (±)-1,2-dithiolane-3-pentanoic acid and (±)-1,2-dithiolane-3-valeric acid, add the stereochemical qualification.

6,8-Dithiooctanoic acid and DL-6,8-thioctic acid occur as established descriptive names. They should be matched to the correct structure and identifier in technical records. Similar sounding sulfur compounds, lipoamide, and reduced dihydrolipoic acid are not interchangeable synonyms for the requested ingredient.

Thioctic acid granules describes the physical supply form, while granular alpha lipoic acid combines that form with the familiar ingredient name. Short abbreviations such as α-LA and LA are convenient once defined. Neither abbreviation establishes assay, particle size, or suitability for a particular regulated product.

CAS NO, EC / EINECS NO AND INCI NAME

- Product name: ALPHA LIPOIC ACID (GRANULAR) (ALA)
- CAS number commonly used for conventional racemic alpha lipoic acid: 1077-28-7
- EC / EINECS number corresponding to that identity: 214-071-2
- INCI name: THIOCTIC ACID
- Molecular formula: C8H14O2S2
- Molecular mass: Approximately 206.33 g/mol
- Chemical class: Sulfur containing heterocyclic carboxylic acid
- Ring structure: 1,2-Dithiolane
- Sulfur functionality: Cyclic disulfide
- Acid functionality: One carboxylic acid group
- Conventional stereochemical form: Racemic R/S mixture when specified as DL or RS
- Physical form requested: Granular
- Enantiomeric composition of a particular delivery: Confirm against the supplied specification
- Carrier or coating content: Confirm whether present
- Separate CAS number created by ordinary granulation: No

The identifiers for Alpha Lipoic Acid (Granular) (ALA) establish the chemical identity of the conventional substance. They do not describe the full composition of a coated or carrier containing preparation. A complete purchasing specification must account for any additional components and the active ingredient basis.

The cosmetic ingredient name THIOCTIC ACID supports nomenclature and ingredient identification. Its existence does not independently establish that a particular industrial grade or finished cosmetic is suitable for sale. Grade qualification and the finished product assessment remain necessary.

Related lipoic acid forms can have different identifiers and physical properties. A quotation for R-alpha-lipoic acid or sodium R-lipoate should be reviewed as a different material choice. The acid equivalent and stereochemical composition must be recalculated where a substitution is considered.

PHYSICAL AND CHEMICAL PROPERTIES

- Appearance: Commonly light yellow to yellow crystalline granules
- Physical state under ordinary handling conditions: Solid
- Molecular mass: Approximately 206.33 g/mol
- Representative melting range for conventional racemic material: Approximately 60–62°C
- Water solubility of the free acid: Very slight; verify concentration, temperature, and pH for the intended preparation
- Ethanol compatibility: Soluble under suitable specified conditions
- Universal oil solubility: Not assigned; evaluate the selected oil or solvent mixture
- Acid behavior: Carboxylic acid functionality; ionization depends on the formulation conditions
- Granule size: Product specific
- Representative commercial size descriptions: Some grades specify ranges such as 20–60 mesh or 30–60 mesh
- Mesh interpretation: State the sieve system and actual passing or retained criteria
- Bulk density: Product and measurement dependent
- Tapped density: Measure separately from loose bulk density
- Flow behavior: Depends on granule size, fines, moisture, and shape
- Assay: Grade and method dependent; high purity commercial examples report limits around 98.5–101.0% or 99.0–101.0% on a stated basis
- Specific rotation for suitable racemic specifications: Near zero under the defined solvent and concentration conditions
- Representative loss on drying limit: Not more than 0.2% in some conventional specifications
- Representative residue on ignition limit: Not more than 0.1% in some specifications
- Related substances: Control by an agreed method and grade specific limits
- Polymeric material: A relevant quality attribute where defined by the specification
- Residual solvents: Process dependent; control individual solvents through appropriate testing
- Elemental impurities: Set application appropriate limits and reporting methods
- Microbiological quality: Establish limits suited to the intended product and use
- Light exposure: Relevant to stability control
- Thermal exposure: Relevant to melting, agglomeration, and chemical stability
- Storage temperature: Follow the instructions for the supplied grade
- Shelf life or retest period: Supported by the applicable product stability data
- Odor: Product specific; evaluate changes against an agreed appearance and sensory description

Alpha Lipoic Acid (Granular) (ALA) these entries separate general chemistry from representative commercial specifications. They should not be combined into a guaranteed set of limits for an unidentified batch. Agree the required test methods and acceptance values for the product being purchased.

A reported assay above 100 percent can result from the analytical basis and uncertainty permitted by a specification. It does not mean that a substance contains more than its entire mass as active chemical. Interpret the number with the method, reference standard, and dry basis correction.

Particle size notation needs more detail than a single mesh number. A minimum passing requirement does not establish the amount of fines or a narrow size range. For production, use the sieve distribution that describes both acceptable granules and undesirable fractions.

Melting range is useful for identity and physical characterization. It is not a guarantee of stability up to the upper endpoint. Manufacturing conditions should be selected through appropriate stability and compatibility studies. Low water solubility deserves particular attention in aqueous products. A yellow mixture that looks uniform can still contain undissolved ingredient. Confirm the physical state and dissolved concentration before calling the preparation a solution.

MOLECULAR STRUCTURE AND REDOX CHEMISTRY

The disulfide ring in Alpha Lipoic Acid (Granular) (ALA) distinguishes alpha lipoic acid from ordinary fatty acids of similar chain length. Reduction can convert that ring to the corresponding dihydrolipoic acid structure with two thiol groups. The oxidized and reduced forms therefore belong to a connected redox system.

Dihydrolipoic acid is chemically related but is not the same supplied ingredient. Its thiol functionality can change reactivity and stability. A specification for the oxidized free acid should not be applied automatically to the reduced form.

The carboxylic acid group provides a separate point of chemical interaction. Its ionization and salt formation influence how the molecule behaves in aqueous media. Changing pH can therefore alter solubility without leaving every other formulation property unchanged.

A hydrophobic carbon framework and an ionizable acid group coexist in the molecule. This helps explain why the ingredient's chemical behavior cannot be summarized by a simple claim of unlimited solubility in water and oil. Practical solubility follows the selected solvent, pH, and concentration.

The sulfur ring also creates a route to ring opening chemistry. Under unsuitable thermal or other conditions, formation of polymeric material can become a quality concern. Control of heat exposure is consequently relevant during both raw material handling and processing.

The word antioxidant describes a chemical or functional role in a particular context. It does not establish that every formulation containing ALA is protected from every oxidation pathway. A laboratory redox result must be interpreted within its method and concentration.

Free ingredient, enzyme bound lipoate, and a formulated oral product represent different contexts. The established biological role of lipoate does not directly predict the performance of a commercial granular preparation. Product development needs evidence for the actual form and intended application.

A molecule's ability to participate in redox reactions is not a guarantee of a clinical outcome. Technical descriptions should keep chemical mechanism, formulation performance, and therapeutic evidence distinct. This supports credible ingredient communication without overstating what the material specification demonstrates.

RACEMIC ALA, R-ALA, AND RELATED FORMS

The chiral center of Alpha Lipoic Acid (Granular) (ALA) allows alpha lipoic acid to exist as R and S enantiomers. Conventional DL material contains both forms, whereas an R specified material requires control of that stereochemical composition. These choices can differ in physical behavior as well as in the evidence applicable to their use.

Naturally occurring enzyme associated lipoate has the R configuration. That fact does not make a racemic product chemically identical to pure R material. A purchaser seeking a specific enantiomer should state that requirement directly. Total HPLC assay may measure the ingredient without separating the enantiomers. A high total result cannot therefore prove an R enriched composition. Where that distinction matters, use a suitable chiral method or another appropriately validated specification.

Specific rotation can support characterization under defined conditions. Solvent, concentration, temperature, and the method influence interpretation. A value close to zero is consistent with a racemate under a suitable procedure but should not replace every compositional check. R-alpha-lipoic acid and sodium R-lipoate are also different material forms. The salt includes a counterion and may have a different water content or hydration state. Equal weighed masses do not necessarily deliver equal free acid equivalents.

A substitution between racemic acid and an R specified product requires review of the formulation and label basis. Physical handling and stability should be reassessed along with composition. The original product's analytical and application results do not automatically transfer.

No universal superiority claim follows from the stereochemical name alone. A formulation developer must consider the intended product, stability requirements, cost, and the relevant evidence. The ingredient identity should match the technical objective rather than a loosely worded marketing preference. Granular form is independent of that choice. A racemate can be granular, and an R specified product can also be prepared in a particulate format. Particle appearance cannot reveal which stereochemical form is present.

WHY GRANULAR FORM MATTERS TO MANUFACTURERS

Compared with Alpha Lipoic Acid (Granular) (ALA), fine powders can behave unpredictably during transfer and metering. A properly designed granular product may reduce some cohesive behavior and support more consistent movement through equipment. The actual advantage depends on the granules and the receiving process.

Bulk flow affects production continuity. Bridging or irregular discharge can create variability even when the formulation has been weighed correctly at the start. Evaluate the offered granules in a hopper or feeding arrangement representative of the intended operation.

Granular thioctic acid can simplify weighing when it produces fewer airborne fines than a finer grade. This benefit should be measured or observed under controlled comparative conditions. A low dust claim cannot be inferred merely from an average particle size.

Granule strength influences how long those physical advantages persist. A product that breaks down during transport or mixing may develop a substantial fine fraction. Assess the material after the handling steps it will actually experience. The same larger size that helps handling may slow dissolution. Surface area, wetting, and the structure of the granule affect the rate at which the ingredient becomes available in a liquid. Flow and dissolution should therefore be evaluated together.

A granular ingredient can segregate from fine excipients. Differences in size and density may cause composition changes during vibration or transfer. A blend that is initially uniform can become less uniform before filling. Physical consistency between lots is valuable for manufacturing. Similar assay values do not compensate for a major change in fines, bulk density, or flow. 

A useful procurement specification should include the physical attributes that control the production line.  The benefit is operational rather than automatically biological. Improved hopper flow or easier capsule filling does not prove faster absorption or higher bioavailability. Those are separate questions that require appropriate finished product evidence.

CAPSULE MANUFACTURING WITH GRANULAR ALA

Hard capsule manufacture with Alpha Lipoic Acid (Granular) (ALA) is a relevant application for a suitably qualified granular ingredient. The principal formulation questions include fill weight, blend uniformity, flow, and release from the finished capsule. The active content is calculated from the supplied assay and the declared composition.

Bulk density influences the volume occupied by a planned fill mass. It is not the same as true material density, and it changes with packing conditions. A capsule size decision should be based on the actual blend rather than a nominal density from another grade.

Excipients can improve handling but also change the active fraction. A carrier with suitable particle characteristics may reduce some segregation, while another may increase it. Select the blend through representative filling trials and content testing.

A glidant is not a substitute for a qualified granular product. It can change surface behavior and improve a particular blend, but it may not resolve a broad particle distribution or weak granules. Additions should be assessed for both flow and finished product release.

Lubricant level and blending history can influence wetting. Excessive lubricant coverage may affect the way the fill interacts with the dissolution medium. The process should define the relevant mixing conditions rather than specifying only ingredient percentages.

Capsule fill consistency should be measured across the run. Beginning, middle, and end samples can reveal changing flow or segregation. A satisfactory average mass may conceal unacceptable individual variation. A capsule shell can contribute moisture exposure during storage. The shell, package, and ingredient need to be assessed as a combined product. An acceptable raw powder stability profile does not establish the capsule's shelf life.

Unit content calculations are manufacturing calculations, not recommendations for consumer intake. The intended serving and label requirements belong to a separate qualified product assessment. A formulation example should not be interpreted as a medical dose instruction.

TABLET DEVELOPMENT AND COMPRESSION

Tablets containing Alpha Lipoic Acid (Granular) (ALA) require a balance between powder handling and compact formation. A granular active may assist feeding, but it does not guarantee suitable compressibility. The binder, filler, disintegrant, and lubrication system determine how the blend behaves under compression.

A compact that reaches the desired hardness may still have unsuitable release. Porosity, wetting, and disintegration contribute to performance after compression. Evaluate those properties together rather than using hardness as the only development endpoint.

Low melting behavior makes thermal history relevant. Equipment friction, prolonged processing, or warm storage can affect a sensitive ingredient. A representative trial should monitor material condition and chemical quality where necessary. Direct compression can reduce the need for a separate wet processing step. Whether it is practical depends on the active and excipient blend. The granular label alone does not establish that a direct compression route will meet the product specification.

If wet granulation is considered, solvent contact and drying need qualification. The ingredient's stability must be evaluated through the actual process. A conventional drying condition used for another active may be unsuitable for thioctic acid. Disintegrants help a tablet break apart but do not necessarily overcome low free acid solubility. Dissolution testing must examine the amount entering the medium as required by the method. Rapid disintegration and rapid dissolution are related but different observations.

A coating can provide handling or appearance benefits, but its processing and moisture effects require review. The finished coated tablet should be included in the stability program. Results from an uncoated core cannot resolve every property of the marketed article.

PREMIXES AND MULTI-INGREDIENT DRY BLENDS

A premix containing Alpha Lipoic Acid (Granular) (ALA) can distribute a relatively small ingredient quantity through a larger carrier mass. Its usefulness depends on mixing, particle compatibility, and the stability of the combined ingredients. A nominally correct recipe does not prove that each sample contains the intended ALA proportion.

Particle size differences create a segregation risk. Coarse active granules and a very fine carrier can separate during transfer even after an effective initial blend. Evaluate the blend after the handling sequence that precedes filling or use. Density differences can also matter. A heavier fraction may move differently during vibration, while lighter particles may concentrate in another region. The relevant observation is the actual blend composition at the delivery point.

An appropriate sampling plan should capture these effects. Samples taken from only one accessible location can give a misleading impression of uniformity. Define the sample size and locations around the intended production and filling process. Multi-ingredient blends introduce chemical compatibility questions. Acids, alkaline constituents, mineral salts, and other ingredients can alter local conditions when moisture is present. Screen the complete blend under representative storage conditions.

Mineral containing formulations deserve particular care because broad claims about metal interaction are not a compatibility specification. The direction and significance of an interaction depend on the chemical forms and the matrix. Measure the relevant quality attributes rather than assuming that an antioxidant ingredient stabilizes every blend.

A carrier containing premix has a lower active fraction than neat granular ALA. The purchasing and formulation records should make that fraction explicit. Confusing the premix mass with the neat ingredient mass creates a predictable content error.

COSMETIC APPLICATIONS OF THIOCTIC ACID

The cosmetic ingredient name for Alpha Lipoic Acid (Granular) (ALA) is Thioctic Acid, associated with alpha lipoic acid. It is considered in formulations where an antioxidant related role is part of development. Suitability depends on the complete cosmetic, its intended use, and the supporting safety and performance assessment.

A cosmetic product needs a strategy for incorporating the free acid. Low water solubility can make direct addition to an aqueous base ineffective. ALA may require a qualified solvent phase, dispersion approach, or another specifically developed delivery system. Granules can be convenient for weighing into a preparation vessel. Their larger size can also make complete dissolution slower than expected. Verify the end state before adding the preparation to the rest of the product.

An emulsion provides both aqueous and oil associated regions, but that does not prove that ALA will dissolve sufficiently in either phase. Partitioning depends on the selected oils, solvents, pH, and ingredient concentration. A visually uniform cream may contain crystals that become more evident during storage.

Crystallization can affect texture and delivered uniformity. Examine the finished product after cooling and throughout a suitable stability study. Microscopy or another appropriate method can help distinguish dissolved ingredient from fine suspended crystals.

A formulation's pH influences more than solubility. Thioctic Acid can change the state of the acid, the stability of the base, and the suitability of preservatives or rheology modifiers. Set pH from the requirements of the whole formula rather than from a single ingredient objective.

A cosmetic antioxidant should not be assumed to replace a preservative. Control of microbial growth requires its own suitable preservation system and validation. Redox functionality and preservation efficacy address different product requirements. Performance claims need evidence on the finished product. An ingredient's chemical activity does not establish a specific visible skin result at every inclusion level. Claim development should match the formula, application pattern, and tests actually performed.

SOLUBILIZATION, WETTING, AND DISPERSION

For Alpha Lipoic Acid (Granular) (ALA), wetting is the first contact between a particle and the liquid phase. It can improve distribution without producing molecular dissolution. This distinction is important when a preparation changes from floating granules to a smooth yellow dispersion.

A cosolvent can improve solvent compatibility in a suitable system. The required composition must be established at the target ALA concentration. Solubility in the cosolvent alone does not guarantee solubility after dilution into the finished aqueous product. Dilution can reveal a hidden limitation. A clear concentrate may develop cloudiness or crystals when its solvent fraction decreases. Check the complete diluted product rather than accepting clarity of the initial stock as the only criterion.

Cooling can also change the dissolved amount. A preparation that appears clear when warm may recrystallize at the intended storage temperature. Development should include the full temperature cycle relevant to manufacturing and distribution. A pH adjustment can increase the ionized fraction of a carboxylic acid. That is a chemical change in the solution state, not simply a physical dissolution aid. Review stability, composition, and labeling implications for the actual product.

Salt formation should be treated as a defined formulation choice. A lipoate salt may have a different mass basis and water response from the free acid. A mixture prepared by neutralization cannot automatically inherit every specification of the original granular acid.

If a suspension is intended, control particle size and redispersibility. A stable appearance at preparation does not establish uniform delivery after standing. The selected thickener should support use without creating an impractical viscosity. A suspension can contain both dissolved and undissolved ALA. The two fractions can respond differently as conditions change. Testing should account for total content and the physical state required by the product design.

Filtration can unintentionally remove active material. A process using a filter needs to establish whether the ingredient is fully dissolved at that stage. Assay before and after the filtration step can reveal losses that visual inspection misses.

STABILITY: TEMPERATURE, LIGHT, AND FORMULATION CONDITIONS

The relatively low melting range of conventional racemic Alpha Lipoic Acid (Granular) (ALA) makes thermal exposure a practical concern. Melting or softening can lead to agglomeration and can accompany chemical changes under unsuitable conditions. A storage or process limit needs stability evidence for the supplied grade.

Ring opening polymerization is a relevant pathway when the disulfide ring is exposed to conditions that favor that reaction. Polymeric material can affect assay interpretation and physical behavior. This is one reason to examine related substances and polymer controls rather than only appearance.

A sample can remain yellow while its quality changes. Color is a useful observation but is not a complete stability assay. Use an appropriate analytical method when establishing a retest period or finished product shelf life. Light exposure should be considered during preparation and storage. The container and handling method can affect the exposure history. A brief protected laboratory preparation and a transparent retail container represent different conditions.

Moisture can influence granule handling and the behavior of a blend. It also creates local conditions for interactions among ingredients. Qualification should reflect the humidity and packaging expected during the product's life. The matrix can protect or destabilize the active. A coating, carrier, solvent, or binder may change the observed behavior, but the direction of that effect needs measurement. A general stabilized description should be supported by data on the specific preparation.

Accelerated testing can help compare candidates. Its interpretation should account for the ingredient's low melting behavior and the relevance of the test conditions to actual storage. A physical transition under a stressed condition can complicate a simple extrapolation.

A stability indicating method should distinguish intact ALA from relevant changes in the sample. Sample extraction and recovery need validation for the matrix. Otherwise, an apparently reduced assay may arise partly from incomplete extraction rather than chemical degradation. Packaging is part of the stability system. Light protection, closure integrity, and moisture management can influence the result. Shelf life should be established for the actual package rather than transferred from a different container.

PHARMACEUTICAL AND ANALYTICAL APPLICATIONS

Thioctic acid in Alpha Lipoic Acid (Granular) (ALA) is used in qualified pharmaceutical manufacturing in applications that depend on the relevant medicinal product requirements. An API grade needs documentation and controls appropriate to that use. A high purity dietary ingredient should not be assumed to meet every pharmaceutical requirement.

The granule format can support solid dosage manufacturing when it fits the validated process. Identity, assay, impurities, and physical properties all contribute to the material specification. Pharmaceutical suitability is not established solely by the word granular or by a minimum purity result.

A pharmacopeial description may define identification and chemical tests. Conformity requires the applicable requirements and methods, not merely one value resembling a monograph limit. Confirm the edition and full scope when that conformity is part of the purchase agreement.

Medicinal indications and claims depend on the finished product and its authorization. They should not be inferred from the bulk ingredient being available for sale. Technical procurement can identify the material without presenting it as a treatment recommendation.

Analytical laboratories also use lipoic acid related materials for method development. A reference standard differs from ordinary bulk granular ingredient because its assigned value and suitability are documented for measurement. High bulk assay does not automatically make a material a certified reference standard.

An assay method needs adequate sample preparation. Granules must be represented in the weighed sample and dissolved or extracted appropriately. Poor preparation can create variability that is incorrectly attributed to the chromatographic system. An achiral method can quantify total conventional ALA without separating R and S forms. A chiral method addresses a different analytical question. Select the method according to whether total content or enantiomeric composition is the required result.

Laboratory solutions should have defined preparation and use conditions. Light, holding time, and solvent can affect the sample or reference solution. Method records should distinguish an original bulk stability claim from the stability of a prepared analytical solution.

COMPARING GRANULAR ALA WITH OTHER INGREDIENT OPTIONS

Compared with Alpha Lipoic Acid (Granular) (ALA), fine alpha lipoic acid powder may dissolve more quickly in a suitable solvent because of its greater exposed surface area. Granules may provide a stronger handling profile in another process. The choice should be based on preparation time, flow, and composition uniformity rather than a universal preference for one size.

Granular material can help reduce some powder handling difficulties. However, it can also introduce segregation against much smaller excipient particles. An advantage in neat ingredient transfer can become a limitation in a poorly matched blend. A coated ALA product can be designed to change stability, taste exposure, or release behavior. Its active fraction and coating composition must be known before comparison. Equal masses of coated preparation and neat granules do not necessarily provide equal active content.

An encapsulated or complexed ingredient is another distinct material choice. It can offer a specific delivery or stability approach, but those benefits belong to the documented preparation. Ordinary granulation does not establish the same molecular association or protection.

R specified acid and racemic acid differ in stereochemical composition. They should be compared with appropriate evidence and a clear formulation objective. Choosing a more expensive form without qualifying stability or content basis can create a technically weak purchasing decision.

Lipoate salts may be considered where aqueous formulation is important. The counterion, hydration, and equivalent mass create additional variables. Better apparent water compatibility does not justify ignoring those differences in the finished specification. Ascorbic acid is a different antioxidant ingredient with different molecular chemistry and formulation behavior. It does not provide the same sulfur containing ring system. Substitution should follow the actual product function and stability requirements, not the broad label antioxidant.

Tocopherol is another chemically distinct option, often relevant to oil containing systems. Its compatibility profile differs from that of thioctic acid. A formula may use either or both ingredients, but a combined system requires its own stability evidence.

Ubiquinone has a different structure, analytical profile, and formulation requirement. Comparisons should consider the intended product and supporting evidence. ALA should not be promoted as a universal replacement for every nutritional or cosmetic antioxidant.

The strongest commercial comparison includes usable active content, impurity control, handling, preparation effort, and finished product performance. Price per kilogram is only one component. The best value is the qualified material that reliably supports the intended production result.

STARTING FORMULATIONS USING ALPHA LIPOIC ACID (GRANULAR) (ALA)

The following Alpha Lipoic Acid (Granular) (ALA) compositions are laboratory and pilot screening balances, expressed as weight percent of the complete stated mixture. They are not validated marketed products, intake recommendations, or evidence of clinical efficacy. A qualified development team must establish suitability, stability, and the applicable finished product requirements.

The ALA quantities refer to the supplied ingredient before any assay correction. Excipients and auxiliaries need grades suited to the intended application. If a coated or diluted active is substituted, recalculate both active content and the amount of carrier introduced.

Preparation routes should avoid unqualified thermal exposure. For aqueous cosmetics, confirm the intended dissolved or dispersed state rather than assuming that the low inclusion level guarantees clarity. The preservative and solvent systems need separate verification within the complete formula.

CAPSULE FILL BLEND FOR HANDLING SCREENING

- ALPHA LIPOIC ACID (GRANULAR) (ALA): 70.00%
- Microcrystalline cellulose of a suitable grade: 29.00%
- Colloidal silicon dioxide: 0.50%
- Magnesium stearate: 0.50%
- Total: 100.00%

This Alpha Lipoic Acid (Granular) (ALA) blend examines a relatively high active fraction in a hard capsule filling study. The selected cellulose should have particle and density characteristics compatible with the granular ingredient. Test flow, segregation, and fill mass consistency on representative equipment.

At a hypothetical 400 milligram fill mass, the blend contains 280 milligrams of supplied ALA before assay correction. This is a manufacturing content calculation, not a suggested serving or daily intake. The finished product dose must be selected through the appropriate product assessment. Evaluate disintegration and the required release method as well as content uniformity. The lubricant and its blending history can influence wetting. Include the intended capsule shell and final package in stability development.

DIRECT COMPRESSION TABLET BLEND SCREEN

- ALPHA LIPOIC ACID (GRANULAR) (ALA): 50.00%
- Microcrystalline cellulose: 30.00%
- Mannitol of a suitable direct compression grade: 15.00%
- Crospovidone: 4.00%
- Colloidal silicon dioxide: 0.50%
- Magnesium stearate: 0.50%
- Total: 100.00%

This Alpha Lipoic Acid (Granular) (ALA) composition is a starting balance for evaluating compression rather than a guarantee of a robust tablet. Granular ALA contributes half of the wet free dry blend mass as supplied material. Assess feeding, tablet mass variation, compact strength, friability, and release under a qualified development procedure.

A hypothetical 500 milligram tablet core contains 250 milligrams of supplied ALA before correction. The number demonstrates the formulation arithmetic only. No therapeutic or consumer use recommendation follows from that illustrative unit size.

Determine whether the blend requires adjustment of filler, binder characteristics, or disintegrant level. Keep changes controlled so their effect can be interpreted. If a coating is added, qualify its processing conditions and the stability of the finished coated tablet.

DILUTED DRY PREMIX FOR UNIFORMITY STUDIES

- ALPHA LIPOIC ACID (GRANULAR) (ALA): 10.00%
- Compatible microcrystalline cellulose carrier: 89.50%
- Colloidal silicon dioxide: 0.50%
- Total: 100.00%

This Alpha Lipoic Acid (Granular) (ALA) premix is a platform for studying distribution of the granular active through a larger carrier mass. It should be sampled after mixing and after representative transfer. Particle mismatch can create segregation even when an initial uniformity result is satisfactory.

At 99 percent as supplied assay, one kilogram of the premix contains approximately 99 grams of intact ALA equivalent. The rest of the calculation depends on the supplier's assay basis and any moisture correction. A carrier containing premix should never be quoted as neat alpha lipoic acid.

The example does not establish suitability for a food product or any unrestricted use. Match the carrier, intended delivery, and documentation to the actual application. Check compatibility and stability before adding further functional ingredients.

COSMETIC COSOLVENT GEL SCREEN

- ALPHA LIPOIC ACID (GRANULAR) (ALA): 0.05%
- Ethanol of a suitable cosmetic grade: 10.00%
- Propylene glycol: 5.00%
- Glycerin: 3.00%
- Compatible hydroxyethylcellulose grade: 0.40%
- Compatible preservative system, as supplied: 0.80%
- Purified water: 80.75%
- Total: 100.00%

This Alpha Lipoic Acid (Granular) (ALA) low inclusion balance explores a cosolvent approach in an aqueous gel. It does not guarantee that the complete preparation will remain clear or that the chosen polymer and preservative will suit the solvent system. Establish solubility after full dilution and examine the product after storage.

The cosolvent system should be evaluated with the selected ALA grade at the stated concentration. Avoid relying on dissolution in an initial concentrate alone. Microscopic inspection and assay can help identify crystallization or changes that visual clarity misses. The finished cosmetic needs a safety assessment and preservation validation. Adjustments to pH or auxiliaries must be included in the complete mass balance. No skin benefit or tolerance claim is assigned to this experimental composition.

COSMETIC EMULSION SCREEN

- ALPHA LIPOIC ACID (GRANULAR) (ALA): 0.05%
- Purified water: 73.95%
- Glycerin: 3.00%
- Propylene glycol: 5.00%
- Caprylic/capric triglyceride: 8.00%
- Compatible emulsifier system: 4.00%
- Cetyl alcohol: 2.00%
- Dimethicone: 3.00%
- Compatible preservative system, as supplied: 1.00%
- Total: 100.00%

This Alpha Lipoic Acid (Granular) (ALA) balance provides an emulsion platform for incorporation and stability screening. It does not specify that ALA is fully soluble in the oil phase or the final emulsion. Develop an appropriate protected incorporation stage without exposing the active to an unqualified hot manufacturing step.

Assess emulsion stability, particle or crystal formation, pH, appearance, and analytical recovery. The emulsifier must be suitable for the stated oil and solvent composition. If a thickener or pH adjustment is needed, revise the water quantity and repeat the relevant tests. Preservation and finished product safety remain separate development requirements. The presence of an antioxidant ingredient does not validate the preservative system. Include the final packaging and the intended use conditions in the qualification program.

ANALYTICAL SOLUTION PREPARATION SCREEN

- ALPHA LIPOIC ACID (GRANULAR) (ALA): 1.00%
- Ethanol of a grade suitable for the analytical method: 99.00%
- Total: 100.00%

This Alpha Lipoic Acid (Granular) (ALA) composition is an illustrative laboratory stock for a method that permits the stated solvent and concentration. It is not a beverage, cosmetic, or consumer preparation. The selected method's requirements take precedence over this example.

Verify complete dissolution and define the permitted holding time. Protect the solution as required by the analytical procedure. If quantitative work needs a reference standard, use the appropriately assigned standard rather than treating the bulk granules as one.

The one percent concentration is a mass fraction. It should not be reported as exactly ten milligrams per milliliter without accounting for density and the method's preparation convention. Analytical records need the actual basis used to calculate concentration.

ASSAY CORRECTION AND FORMULATION ARITHMETIC

A formulation using Alpha Lipoic Acid (Granular) (ALA) can target supplied ingredient mass or pure ALA equivalent. These are different quantities whenever assay is below the nominal pure value or the product contains a carrier. State the intended basis in both the recipe and the finished product calculation.

For an as supplied assay of 99 percent, one kilogram of ingredient contributes approximately 0.99 kilogram of ALA. To provide one kilogram of equivalent active, the calculated ingredient mass is about 1.0101 kilograms. This assumes the assay accurately represents the quantity required by the calculation.

A dried basis result needs a separate moisture consideration when used for an as supplied weight. If loss on drying reflects the relevant removable fraction, that fraction can affect the conversion. Confirm the analytical convention instead of applying an automatic correction to every certificate.

A coated material can have a substantially lower active fraction than neat granules. If a preparation is specified at 80 percent active, equal gross masses do not deliver the same content as a high assay neat ingredient. The carrier contribution also changes the formulation's composition.

A dry blend percentage is different from content per unit. Multiply the actual fill or core mass by the ingredient fraction and the applicable assay factor. Then verify the result through the finished product method rather than relying exclusively on the theoretical balance.

For liquid formulations, weight percent and mass per volume are different expressions. Density and temperature affect a volume based concentration. Maintain consistent units when transferring a formula to laboratory instructions or manufacturing records.

Molar concentration can be useful in laboratory comparisons. The molecular mass of approximately 206.33 g/mol applies to the conventional free acid, while a salt or hydrated preparation needs a different calculation. Comparing chemical equivalents requires the correct form and composition.

A nominal overage should not be used to compensate blindly for unexplained losses. Investigate recovery, segregation, or degradation and establish the actual process behavior. Any overage requires a justified product development basis and appropriate review.

CHOOSING THE RIGHT QUALITY GRADE

The intended application should determine the quality specification for Alpha Lipoic Acid (Granular) (ALA). A dietary ingredient, pharmaceutical active, cosmetic ingredient, and research reagent can require different documentation and controls. A common CAS number does not make those grades commercially interchangeable.

For dietary supplement manufacturing, examine identity, assay, impurities, elemental contaminants, microbiological quality, and the physical characteristics needed for production. Documentation should support the intended market and product type. A general food grade description needs a defined specification behind it.

Pharmaceutical use requires the relevant API quality framework and product specific qualification. The applicable monograph, manufacturing controls, and supporting records should be identified where required. A certificate showing high assay alone is insufficient to establish that broader suitability.

Cosmetic use requires appropriate purity and a composition compatible with the finished product assessment. The INCI name helps identify the ingredient but does not resolve solvent compatibility or finished product safety. The formulation developer should qualify the offered grade for the actual cosmetic system.

Research grade is selected around the experiment and analytical requirement. It may be unsuitable for commercial oral or topical manufacture despite a high nominal purity. Laboratory convenience and production suitability are separate purchasing questions.

The physical format should be part of the grade decision. A suitable assay range with an unsuitable particle distribution can create filling or blending problems. Agree both chemical and physical acceptance criteria before comparing quotations.

A low residual solvent grade can be useful where that attribute is important. The claim should identify the relevant solvents, detection limits, and actual limits. Solvent free should not be interpreted as an unsupported statement that no solvent molecule can be present.

A coated or carrier containing grade needs a complete composition description. Its specification should distinguish total preparation mass from active ingredient content. A purchasing comparison that ignores the carrier can produce an incorrect cost per unit of usable ALA.

IDENTITY, ASSAY, AND RELATED SUBSTANCES

Identity testing of Alpha Lipoic Acid (Granular) (ALA) should confirm that the supplied material is the intended chemical. Infrared spectroscopy and chromatographic comparison are examples of suitable approaches within an established procedure. Identity and quantitative assay answer different questions.

A chromatographic main peak alone does not describe every impurity. A method needs sufficient separation and an appropriate detection approach for the relevant related substances. Review the method's scope when an impurity result is important to the purchasing specification.

HPLC area percent is not automatically identical to mass assay. Response factors, sample preparation, and the calculation convention influence interpretation. Two certificates using different bases should not be compared as if their results represented exactly the same measurement.

A reference standard helps connect the assay with an assigned value. Its potency, handling, and preparation need to be incorporated correctly into the calculation. An inaccurate standard correction can affect every batch result even when sample handling is consistent.

Polymeric material may require a separate method or specification. Some larger or altered species may not behave like intact ALA during extraction or chromatography. A total related substances statement should not be assumed to cover every possible change without checking the procedure.

Loss on drying provides information about material removed under specified conditions. It is not always identical to a selective water measurement. Use the result according to its method and the application requirement. Residue on ignition assesses a different quality attribute from organic related substances. It can help characterize nonvolatile inorganic residue under the specified test. A low ash result does not establish low organic impurity content.

A complete quality profile connects these measurements rather than ranking a material by one number. Assay, identity, impurities, and physical condition together support the decision. The tests should reflect the risks capable of affecting the intended product.

RESIDUAL SOLVENTS, ELEMENTAL IMPURITIES, AND MICROBIOLOGY

Residual solvent control for Alpha Lipoic Acid (Granular) (ALA) follows the manufacturing process and the intended use. The relevant solvents should be identified individually with suitable limits. A broad statement about total solvent does not necessarily replace individual measurements where those are required.

Gas chromatography can support residual solvent testing under a qualified method. Sample preparation and sensitivity need to suit the limits being claimed. A report of not detected is meaningful only with the method's detection or quantification capability understood. Elemental impurity requirements also depend on the application. Individual elements and their limits are more informative than an undefined heavy metals free statement. Agree the reporting units and method so the results can be compared consistently.

A microbiological specification should state the counts and the organisms required by the intended product framework. Sampling and method suitability are part of that assessment. A dry chemical's appearance does not demonstrate acceptable microbiological quality.

Packaging integrity helps preserve the quality established at batch release. Repeated exposure or poorly controlled repacking can introduce additional variability. Where repacking is part of the supply route, understand how identification and quality are maintained.

Additional declarations may be needed for a customer's product or purchasing system. Request those that are relevant to the intended use and confirm their availability for the actual grade. Avoid assuming that every product offered under the same chemical name carries the same set of declarations.

PARTICLE CHARACTERIZATION AND POWDER PERFORMANCE

For Alpha Lipoic Acid (Granular) (ALA), loose bulk density measures the occupied volume of a powder or granule bed under a defined filling procedure. Tapped density measures a more compacted condition after a stated method. Their difference can provide useful context but does not replace a direct feeding test.

Particle size distribution should capture both granules and fines. A supplier's range may describe a sieve fraction rather than every particle in the batch. Clarify how much material outside the preferred range is permitted. Granule shape can affect flow and packing. Rounded particles and irregular fragments can behave differently even when their sieve sizes are similar. Inspect representative material when appearance is relevant to the equipment's performance.

Attrition during handling can change the distribution. Transfer, mixing, and conveying may create particles smaller than those present in the delivered package. Evaluate the material after the realistic handling steps where the line is sensitive to fines. A dissolution comparison should use controlled mixing and a defined solvent. A smaller particle can disappear more quickly without the material having a higher equilibrium solubility. Distinguish dissolution rate from the maximum amount that can dissolve.

Physical tests should use samples representative of the complete batch. Granules and fines can separate within a container during movement. A small sample collected from the top may not represent the material entering production later. A useful physical specification can reduce operational variability. It should include the properties that actually influence weighing, feeding, mixing, or release. Adding tests without a process purpose increases paperwork without necessarily improving material selection.

STORAGE, PACKAGING, AND RETEST CONTROL

Store Alpha Lipoic Acid (Granular) (ALA) according to its documented conditions. Protection from heat, light, moisture, and contamination is commonly relevant. The specific temperature limit and retest period belong to the offered grade and its supporting data.

Different suppliers may recommend different storage temperatures. That can reflect their product, package, and stability program. Do not combine the most permissive temperature from one product with the longest shelf life from another.

The package should maintain the intended protection during transport and routine use. Closure quality, light transmission, and moisture ingress can influence the result. A package that performs well while unopened may require a separate procedure after opening.

Record the lot number, receipt date, and applicable expiry or retest information. Where the container is used repeatedly, an opening record can support investigation of later changes. Keep the remaining material identified throughout transfer and storage.

Temperature excursions deserve review against the product data. A short warm exposure is not automatically equivalent to prolonged storage at the same temperature. The significance depends on duration, conditions, and the material's actual response.

Inspect incoming granules for unusual caking, discoloration, or foreign matter. Those observations should trigger an appropriate quality review rather than an unsupported assumption that the material remains unchanged. Chemical testing may be needed when exposure history is uncertain.

A retest date indicates a point for reassessment under the applicable system. It should not be extended merely because the material looks acceptable. Use the supplier guidance and qualified testing where continued use is being considered. Finished products need their own stability data. Excipients, liquids, capsule shells, and packaging change the system in which ALA is held. The raw ingredient's retest period cannot be copied directly onto a marketed product.

SAFETY FOR RAW MATERIAL HANDLING AND FINISHED PRODUCT DEVELOPMENT

For handling Alpha Lipoic Acid (Granular) (ALA), use the current safety data sheet for the supplied material when planning handling. Supplier classifications for conventional alpha lipoic acid can include harmful effects if swallowed and skin or eye irritation. Granules still require suitable controls during weighing, transfer, and preparation.

Limit airborne material and avoid unnecessary disturbance that creates fines. Protective gloves and eye protection should be chosen for the task and the relevant chemical contact. A cleaner handling format does not eliminate occupational precautions.

Solvent based development introduces the solvent's own requirements. Equipment, ventilation, and handling should be suitable for the actual solvent mixture. The analytical ethanol stock example is a laboratory preparation and must be treated accordingly.

Personnel should know the applicable first aid and spill procedures. Keep chemical handling separate from eating and drinking activities. Clear identification reduces the risk of confusing bulk ingredient with a finished consumer product.

An ingestible product requires a separate safety assessment. Alpha lipoic acid intake has been associated with insulin autoimmune syndrome in susceptible individuals, which can involve hypoglycemia. Ingredient purity and granular form do not remove that concern.

A manufacturing formula is not a substitute for selecting an appropriate intake level and label precautions. Intended users, medical context, and other ingredients can affect the assessment. Qualified product and medical review should address those questions where relevant.

The antioxidant description should not be interpreted as a claim of harmlessness at any quantity. Nor does a technical ingredient specification establish treatment of a disease. Product communication should follow the evidence and the intended product's requirements.

A topical cosmetic also needs evaluation of the complete formula. Solvents, pH, preservatives, and the active concentration all contribute to suitability. A small inclusion percentage does not independently demonstrate tolerance for every user or use pattern.

TDS, SDS, COA, AND SUPPLIER QUALIFICATION

The technical data sheet for Alpha Lipoic Acid (Granular) (ALA) should describe identity, physical form, and the useful technical properties of the offered grade. It provides a preliminary selection basis. Distinguish typical observations from guaranteed delivery limits.

The safety data sheet addresses hazards and handling for the supplied composition. A document for a sodium salt, an R enriched product, or a coated preparation is not automatically appropriate for conventional neat granular acid. Match the document with the quotation and delivered material.

The certificate of analysis should identify the delivered lot and its reported results. Check assay basis, methods where provided, and the properties required by the purchase specification. A sample certificate is useful for discussion but is not the release record for a different delivery.

Where a pharmacopeial claim is important, establish its scope. Ask which requirements are controlled and what documentation supports the stated conformity. One familiar assay range does not establish full compliance with a standard. The supplier's change notification arrangement can be important after qualification. Changes to granulation, solvent route, particle limits, or coating composition may affect a validated process. Agree which changes need technical review before subsequent supply.

Representative samples help qualify both chemistry and manufacturing behavior. Test them using the intended blend or formulation instead of relying only on neat material observations. A sample that fills well alone may still segregate when mixed with excipients.

A purchasing description should state the exact product, conventional chemical identity, required stereochemical form, and whether neat or coated material is expected. Add the physical and quality limits relevant to the application. This avoids a quotation that is chemically related but unsuitable for the process.

Compare commercial offers on a consistent active basis. Package size, assay, carrier content, documentation, and delivery conditions can change the effective comparison. A lower gross price is not necessarily a lower cost per qualified unit of active ingredient.

TROUBLESHOOTING COMMON DEVELOPMENT PROBLEMS

Poor hopper discharge of Alpha Lipoic Acid (Granular) (ALA) may reflect moisture, fines, or an equipment mismatch. Compare the incoming particle distribution and the handling history with an accepted batch. Adding a flow aid without identifying the cause can conceal rather than resolve variability.

A blend assay that changes during filling can indicate segregation. Examine samples across the run and after representative transfer. A correct initial laboratory mixture does not prove stable composition throughout production.

Slow dissolution can follow larger particles or inadequate wetting. Confirm that the solvent can dissolve the intended amount at equilibrium before adjusting mixing. More intense agitation cannot permanently overcome an equilibrium solubility limit.

Crystals after cooling can indicate a supersaturated or insufficiently solubilized preparation. Review the complete solvent fraction and storage temperature. A clear warm concentrate may not represent the condition of the finished product.

A falling assay needs a stability and recovery investigation. Check sample extraction, reference preparation, and analytical suitability before concluding that every decrease is chemical degradation. If degradation is confirmed, examine heat, light, moisture, and ingredient compatibility.

A tablet can disintegrate yet release too little dissolved active within the test period. Evaluate both the physical breakup and the free acid's dissolution in the specified medium. Changing the disintegrant alone may not solve the limiting step.

Unexpected sensory changes in a cosmetic require review of the complete system. Ingredient condition, emulsion behavior, and the preservative or solvent system can each contribute. Compare with a matched base formulation to isolate the active's effect.

When a new lot behaves differently, test it alongside an accepted retained sample under identical conditions. Compare assay, impurities, particle distribution, density, and exposure history. This creates a more reliable basis for corrective action than comparing unrelated production runs.

FREQUENTLY ASKED QUESTIONS ABOUT ALPHA LIPOIC ACID (GRANULAR) (ALA)

What is ALPHA LIPOIC ACID (GRANULAR) (ALA)?
It is alpha lipoic acid supplied in a granular physical format. The underlying chemical is a sulfur containing carboxylic acid with a cyclic disulfide structure.

What is the CAS number?
The conventional racemic ingredient commonly uses CAS 1077-28-7. Confirm the offered composition if a different enantiomeric form or salt is intended.

What is the EC / EINECS number?
The corresponding EC / EINECS number is 214-071-2. The number does not specify granule size or whether an additional carrier is present.

What is its INCI name?
The ingredient name is THIOCTIC ACID. Cosmetic suitability still requires qualification of the grade and assessment of the complete product.

Are thioctic acid and alpha lipoic acid the same ingredient?
They are established names for the same core chemical identity. The specific stereochemical and physical form should remain clear in the specification.

Does ALA always mean alpha lipoic acid?
No, the abbreviation can have other meanings in different contexts. Define it with the full name and CAS number in technical records.

Is granular ALA a new chemical molecule?
No, ordinary granulation changes physical presentation rather than chemical identity. Any coating or carrier needs separate declaration.

Is a granular product automatically coated?
No, granular and coated are different descriptions. Ask for the composition and active content of the actual offered preparation.

What is the molecular formula?
The conventional free acid formula is C8H14O2S2. Its molecular mass is approximately 206.33 g/mol.

Is the conventional product racemic?
Material specified as DL or RS is racemic. Granular appearance alone cannot establish the R/S ratio.

Can ordinary total assay prove R purity?
Not necessarily, because an achiral assay can measure total ALA without separating the enantiomers. Use a suitable chiral method where that composition is required.

Is the free acid readily water soluble?
No, it is very slightly soluble in water. A clear aqueous preparation needs a qualified solvent, ionization, or delivery strategy.

Does soluble in ethanol mean soluble in a diluted aqueous gel?
No, dilution changes the solvent environment and can cause precipitation. Check the final formula and its storage behavior.

What melting range is typical for conventional racemic ALA?
Suitable conventional specifications commonly report approximately 60–62°C. This range is not a universal safe processing threshold.

Why select granules instead of fine powder?
A qualified granular grade may improve weighing, feeding, or flow in a particular process. Compare those benefits with dissolution rate and segregation behavior.

Does granular form guarantee better bioavailability?
No, physical handling advantages do not establish absorption or clinical performance. Those questions require evidence for the finished product.

Can neat and coated ALA be substituted at equal mass?
Not without checking active fraction and composition. Recalculate the active equivalent and qualify the resulting formulation.

Can it be used in capsule development?
A suitable grade can be evaluated in a capsule fill blend. Flow, content uniformity, release, shell compatibility, and stability need testing.

Can it be directly compressed into tablets?
That depends on the full blend and processing conditions. Granular form does not guarantee compressibility or acceptable dissolution.

Is ALA a cosmetic preservative?
An antioxidant related role does not validate microbial preservation. The complete cosmetic needs its own suitable preservation system.

Why does a specification allow assay above 100 percent?
Analytical basis and method uncertainty can account for that range. It does not imply that the material contains more than its total mass as active ingredient.

What should be checked after warm transport?
Review the exposure against the product's stability guidance and inspect the material condition. Appropriate testing may be needed if quality is uncertain.

Which documents should a purchaser request?
Request the applicable TDS, SDS, and batch COA requirements. Add composition, stereochemical, or conformity documentation where the intended application requires it.

Are the example unit contents intake recommendations?
No, they illustrate manufacturing arithmetic only. Intake and product labeling require a separate qualified assessment.

What information makes a supplier inquiry more useful?
State the application, required grade, stereochemical form, assay basis, particle requirements, quantity, and documentation needs. Identify whether neat, coated, or carrier containing material is acceptable.

ALPHA LIPOIC ACID (GRANULAR) (ALA) SUPPLY FROM ATAMAN KIMYA

To source Alpha Lipoic Acid (Granular) (ALA), contact Ataman Kimya with the intended application. Identify whether the project concerns capsules, tablets, a premix, a cosmetic, or another qualified use. A clear application description helps focus the discussion on the relevant grade and physical requirements.

Specify the required chemical and stereochemical identity, active content basis, and whether a neat granular product is expected. Include any limits for impurities, residual solvents, moisture, microbiology, or particle distribution. Ask for the documents applicable to the offered material and confirm availability for the actual quotation.

Provide the expected quantity, packaging preference, destination, and planned qualification work. For a sensitive line, explain the flow, uniformity, or stability tests that the sample must support. These details help connect the proposed supply with the manufacturing requirement.

A dependable purchasing basis combines documented identity with representative application performance. Review the specification and supply conditions with Ataman Kimya before selecting the material for routine use. The objective is a qualified ingredient choice that can be checked consistently when subsequent batches arrive.